| abstract |
The present invention provides an isolated monoclonal antibody that specifically binds to human CD40. Nucleic acid molecules encoding the antibodies are also provided, as are expression vectors, host cells and methods for expressing the antibodies. The invention also provides immunoconjugates, bispecific molecules, chimeric antigen receptors, oncolytic viruses and pharmaceutical compositions comprising the antibodies, as well as methods of treatment using the antibodies of the invention. |